Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25061620 | 0.88 | ATM (0.40) | ATMPOLBMEN1KMT2ARAB9A | |
| SCHEMBL12203107 | 0.82 | ATM (0.38) | ATMPOLBMEN1KMT2AGAA | |
| SCHEMBL12203110 | 0.80 | TP53 (0.39) | ATMPOLBMEN1KMT2AGAA | |
| SCHEMBL25061451 | 0.80 | ATM (0.38) | ATMPOLBMEN1KMT2ALMNA | |
| SCHEMBL25061771 | 0.78 | ATM (0.36) | ATMPOLBMEN1KMT2ARAB9A | |
| SCHEMBL25061476 | 0.78 | ATM (0.37) | ATMPOLBMEN1KMT2ALMNA | |
| SCHEMBL12203113 | 0.78 | CRBN (0.37) | ATMPOLBGAA | |
| SCHEMBL25061467 | 0.77 | ATM (0.36) | ATMPOLBMEN1KMT2ALMNA | |
| SCHEMBL25061531 | 0.77 | ATM (0.36) | ATMPOLBMEN1KMT2ALMNA | |
| SCHEMBL25061746 | 0.75 | ATM (0.35) | ATMPOLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053699-A1 | SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230053699-A1 | SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | CYP4X1, CYP4F11, CBR3 | ATM 4299/4885POLB 3229/4885MEN1 4688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.